Amsterdam, February 2, 2021 - The Canadian Neuromuscular Disease Registry (CNDR) was launched in 2010 to increase efficient patient access to cutting-edge research and clinical trials, to increase ...

The latest guidance in addressing proper monitoring and reversal of neuromuscular blockade drugs during general anesthesia—a major advance in patient safety and satisfaction—was published today in ...

A literature review by a University at Buffalo researcher reveals two noteworthy findings related to COVID-19 and patients with neuromuscular disorders. The research shows that the novel coronavirus ...

Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.

In a recent study published in JAMA Internal Medicine, researchers examine the potential of neuromuscular training to prevent chemotherapy-induced peripheral neuropathy (CIPN). Study: Preventive ...

Neuromuscular training improves balance, stability, coordination and reaction speed, increasing patients’ ability to perform daily chores and allowing them to gain quality of life. Ten lecturers from ...

In the Baby-COMET trial, Nexviazyme met all primary and secondary endpoints, teeing it up for potential label expansion.

Because researchers have made such striking progress in developing drugs to treat neuromuscular diseases, Scott Delp, PhD, was surprised to learn that scientists conducting clinical trials were still ...

Spot Biosystems, a gene therapy company pioneering a novel non-viral extracellular vesicle (EV) delivery platform for genetic ...

A literature review by a UB researcher reveals two noteworthy findings related to COVID-19 and patients with neuromuscular disorders. The research shows that the novel coronavirus can bring on ...